Cargando…

Exploration of the Core Pathways and Potential Targets of Luteolin Treatment on Late-Onset Depression Based on Cerebrospinal Fluid Proteomics

Cognitive deficiency is one of the fundamental characteristics of late-onset depression (LOD). Luteolin (LUT) possesses antidepressant, anti-aging, and neuroprotective properties, which can dramatically enhance cognition. The altered composition of cerebrospinal fluid (CSF), which is involved in neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kaige, Li, Huizhen, Zeng, Ningxi, Li, Bozhi, Yao, Gaolei, Wu, Xiaofeng, Xu, Hanfang, Yan, Can, Wu, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958965/ https://www.ncbi.nlm.nih.gov/pubmed/36834894 http://dx.doi.org/10.3390/ijms24043485

Ejemplares similares

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2022)

The risk of offspring mood and anxiety disorders in the context of prenatal maternal somatic diseases: a systematic review and meta-analysis
por: Gong, Xiayu, et al.
Publicado: (2022)

Causal relationships between blood lipids and major psychiatric disorders: Univariable and multivariable mendelian randomization analysis
por: Li, Bozhi, et al.
Publicado: (2023)

Late-onset spinal subdural hematoma following cerebrospinal fluid drainage tube removal
por: Hattori, Masashi, et al.
Publicado: (2022)

Quantitative proteomics of delirium cerebrospinal fluid
por: Poljak, A, et al.
Publicado: (2014)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023)

Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia
por: Chen, Kai, et al.
Publicado: (2023)

Establishing the Proteome of Normal Human Cerebrospinal Fluid
por: Schutzer, Steven E., et al.
Publicado: (2010)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Proteomics Study on the Cerebrospinal Fluid of Patients with Encephalitis
por: Xiong, Liu-Lin, et al.
Publicado: (2021)

Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
por: Prague, J K, et al.
Publicado: (2014)

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer’s disease
por: Sutphen, Courtney L., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics reveal potential protein targets of JiaWeiSiNiSan in preventing chronic psychological stress damage
por: Wang, Han-Zhang, et al.
Publicado: (2021)

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
por: Bai, Shumei, et al.
Publicado: (2009)

Data for a comprehensive map and functional annotation of the human cerebrospinal fluid proteome
por: Zhang, Yang, et al.
Publicado: (2015)

Identification and proteomic profiling of exosomes in human cerebrospinal fluid
por: Street, Jonathan M, et al.
Publicado: (2012)

Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
por: Gómez-Baena, Guadalupe, et al.
Publicado: (2017)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Late-Onset Intractable Cerebrospinal Fluid Leakage After Stereotactic Radiotherapy After Resection of Giant Nonfunctioning Pituitary Adenoma
por: Nihonmatsu, Ayano, et al.
Publicado: (2019)

Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
por: Marelli, Cecilia, et al.
Publicado: (2015)

Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis
por: Huang, Jeffrey T.-J, et al.
Publicado: (2006)

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
por: Tijms, Betty M, et al.
Publicado: (2020)

The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome
por: Leifsdottir, Kristin, et al.
Publicado: (2022)

Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis
por: Chen, Juncao, et al.
Publicado: (2022)

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
por: Isgren, Anniella, et al.
Publicado: (2022)

Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
por: Kangas, Petra, et al.
Publicado: (2023)

Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus
por: Hu, Chaojun, et al.
Publicado: (2015)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics
por: Nardi Cesarini, Elena, et al.
Publicado: (2020)

Glycosylation of luteolin in hydrophilic organic solvents and structure–antioxidant relationships of luteolin glycosides
por: Xu, Tingting, et al.
Publicado: (2022)

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
por: Lauridsen, Camilla, et al.
Publicado: (2017)

Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy
por: Tan, Ning, et al.
Publicado: (2020)

A chronic fatigue syndrome – related proteome in human cerebrospinal fluid
por: Baraniuk, James N, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_78o4qtcpe6kc0sgoott5lrhsqe